|
2023
|
Invention
|
Biological therapeutics for infection-relating disorders or conditions.
The present invention di... |
|
2022
|
Invention
|
Antibodies against n-acetylglucosamine and n-acetyl-galactosamine. It provides antibodies and chi... |
|
|
Invention
|
Methods of treating gastrointestinal diseases characterized by inflammatory cells. The invention ... |
|
|
Invention
|
Applications of analogs or derivatives of sialic acids.
Provided are compositions or products co... |
|
|
Invention
|
Compositions and products for infectious or inflammatory diseases or conditions. Composition and ... |
|
2021
|
Invention
|
Safer vaccines.
The invention provides safer vaccines that induce less adverse reactions particu... |
|
2020
|
Invention
|
Saccharide-based biomarkers and therapeutics. The invention provides antibodies that specifically... |
|
2019
|
Invention
|
Glycan-based drugs, therapies and biomarkers. The present disclosure discloses simple and efficie... |
|
|
Invention
|
Biological therapeutics for infection-relating disorders or conditions. The present invention dis... |
|
2015
|
Invention
|
Saccharide-based biomarkers and therapeutics. Provided are antibodies that specifically bind to a... |
|
2007
|
Invention
|
Process for identification of molecular mimicry and the uses thereof. The present invention discl... |
